SIGA Technologies, Inc. (NASDAQ:SIGA) Shares Sold by BNP Paribas Financial Markets

BNP Paribas Financial Markets lessened its holdings in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) by 84.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,322 shares of the company’s stock after selling 63,525 shares during the period. BNP Paribas Financial Markets’ holdings in SIGA Technologies were worth $76,000 at the end of the most recent quarter.

A number of other institutional investors have also recently made changes to their positions in the business. Advantage Alpha Capital Partners LP purchased a new stake in SIGA Technologies in the third quarter valued at about $276,000. Larson Financial Group LLC acquired a new stake in SIGA Technologies in the 3rd quarter worth approximately $30,000. Algert Global LLC purchased a new stake in SIGA Technologies during the 3rd quarter worth approximately $464,000. Charles Schwab Investment Management Inc. increased its stake in SIGA Technologies by 5.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 507,262 shares of the company’s stock valued at $3,424,000 after purchasing an additional 24,101 shares in the last quarter. Finally, Foundry Partners LLC purchased a new position in shares of SIGA Technologies in the third quarter worth $2,801,000. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Trading Up 5.2 %

NASDAQ:SIGA opened at $6.03 on Friday. The firm has a fifty day simple moving average of $6.78 and a 200-day simple moving average of $7.74. SIGA Technologies, Inc. has a 12 month low of $4.26 and a 12 month high of $12.83. The company has a market capitalization of $430.57 million, a P/E ratio of 5.03 and a beta of 0.89.

SIGA Technologies (NASDAQ:SIGA) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. The business had revenue of $10.01 million for the quarter. Equities analysts forecast that SIGA Technologies, Inc. will post 1.04 EPS for the current year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.